New educational campaign aims to educate individuals at risk for glaucoma and raise funding for glaucoma research.
During the month of January, Glaucoma Awareness Month, Bausch + Lomb and GRF will share educational resources to educate individuals who may be at risk for glaucoma and empower them to take an informed and active role in their eye health.
Bausch + Lomb Corp. and the Glaucoma Research Foundation (GRF) today announced the U.S. launch of Screen, Protect, Cure, a campaign designed to provide educational resources and raise awareness of glaucoma, a leading cause of irreversible blindness, during Glaucoma Awareness Month.1
"We are proud to collaborate with Glaucoma Research Foundation to provide critical information about this serious eye disease and underline the negative toll it can have if left untreated," said Christina Ackermann, president, Ophthalmic Pharmaceuticals, Bausch + Lomb. "Glaucoma can affect individuals of all ages and only half of those affected are aware they have it, so it’s important that we share risk factors, how to get tested and what treatment options are available. Through Screen, Protect, Cure, we hope to help support patients in every step of their treatment journey."1
During the month of January, Glaucoma Awareness Month, Bausch + Lomb and GRF will share educational resources to educate individuals who may be at risk for glaucoma and empower them to take an informed and active role in their eye health. The campaign also features a fundraising challenge that will match every dollar raised up to $20,000 in support of GRF research for a potential cure for glaucoma.
"Glaucoma Awareness Month provides a great opportunity to share information about this sight-threatening disease and remind people there are steps they can take to help preserve their vision," said Thomas M. Brunner, president and CEO, GRF. "Visiting an eye care provider on an annual basis and paying attention to visual function are the best things someone can do to avoid the irreversible damage from glaucoma. Although there is currently no cure, our fight to prevent visual disability is ongoing, and we are grateful for the collaboration of organizations, such as Bausch + Lomb, who share this commitment with us."